Nanophage Technologies Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 6

Nanophage Technologies General Information

Description

Developer of nanorod technology designed to enhance immunoassay-based diagnostics and drug discovery processes. The company offers functionalized nanorods that improve assay sensitivity, enabling healthcare providers and research organizations to detect diseases earlier and support faster discovery processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Riddet Road
  • Science Tower D
  • Palmerston North, 4410
  • New Zealand
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • Riddet Road
  • Science Tower D
  • Palmerston North, 4410
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanophage Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 31-Dec-2026 Upcoming Startup
4. Later Stage VC 17-Feb-2026 Completed Product Development
3. Later Stage VC 03-Feb-2022 Completed Product Development
2. Early Stage VC Completed Startup
1. Spin-Off 01-Jan-2012 Completed Startup
To view Nanophage Technologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanophage Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanophage Technologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Zealand Growth Capital Partners Venture Capital Minority
Bridgewest Group Venture Capital Minority
Bridgewest Ventures Accelerator/Incubator Minority
Callaghan Innovation Government Minority
Flying Kiwi Angels Angel Group Minority
You’re viewing 5 of 6 investors. Get the full list »

Nanophage Technologies FAQs

  • When was Nanophage Technologies founded?

    Nanophage Technologies was founded in 2012.

  • Where is Nanophage Technologies headquartered?

    Nanophage Technologies is headquartered in Palmerston North, New Zealand.

  • What is the size of Nanophage Technologies?

    Nanophage Technologies has 9 total employees.

  • What industry is Nanophage Technologies in?

    Nanophage Technologies’s primary industry is Diagnostic Equipment.

  • Is Nanophage Technologies a private or public company?

    Nanophage Technologies is a Private company.

  • What is Nanophage Technologies’s current revenue?

    The current revenue for Nanophage Technologies is .

  • How much funding has Nanophage Technologies raised over time?

    Nanophage Technologies has raised $2M.

  • Who are Nanophage Technologies’s investors?

    New Zealand Growth Capital Partners, Bridgewest Group, Bridgewest Ventures, Callaghan Innovation, and Flying Kiwi Angels are 5 of 6 investors who have invested in Nanophage Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process